Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Surg Today. 2021 Nov;51(11):1795-1804. doi: 10.1007/s00595-021-02268-8. Epub 2021 Apr 9.
Although endoscopic naso-biliary drainage (ENBD) is a popular preoperative biliary drainage (PBD) method for patients with perihilar biliary malignancy (PHBM), patient discomfort caused by the nasal tube remains a problem. This study aimed to analyze the safety and efficacy of PBD with the placement of a plastic stent above the papilla [inside-stent (IS)] as a bridging therapy.
The outcomes of 78 patients with potentially resectable PHBM, of whom 29 underwent IS placement and 49 underwent ENBD were evaluated.
The stent-associated complication rates were not different between the two groups (7% in the IS group and 10% in the ENBD group, P = 0.621). Catheter dislocation occurred less frequently (0% vs. 22%, P = 0.016), and the median time to recurrent biliary obstruction was longer (not reached vs. 32 days, P = 0.039) in the IS group than in the ENBD group. Among the patients who underwent resection, their postoperative severe complication rates were not substantially different (26% vs. 25%, P = 0.923).
IS placement is a possible alternative to ENBD as a bridge to a definitive operation for patients with resectable PHBM and a prospective trial to prove its feasibility and safety is therefore warranted.
尽管内镜鼻胆管引流(ENBD)是治疗高位胆管恶性肿瘤(PHBM)患者的一种常用术前胆道引流(PBD)方法,但鼻管引起的患者不适仍然是一个问题。本研究旨在分析经乳头上方塑料支架置入(IS)作为桥接治疗的 PBD 的安全性和有效性。
评估了 78 例潜在可切除 PHBM 患者的治疗结果,其中 29 例行 IS 置入,49 例行 ENBD。
两组支架相关并发症发生率无差异(IS 组为 7%,ENBD 组为 10%,P=0.621)。IS 组的导管脱位发生率较低(0% vs. 22%,P=0.016),复发性胆道梗阻的中位时间更长(未达到 vs. 32 天,P=0.039)。在接受手术切除的患者中,术后严重并发症发生率无显著差异(26% vs. 25%,P=0.923)。
IS 置入是一种替代 ENBD 的方法,可作为可切除 PHBM 患者确定性手术的桥梁,因此有必要进行前瞻性试验以证明其可行性和安全性。